DCEG News Updates
The latest news and research findings from the Division of Cancer Epidemiology and Genetics.
-
Measuring the Impact of Publications by Joseph Fraumeni
Several indices have been developed as benchmarks to estimate the overall impact of a scientist’s work. The two most commonly used are the Thomson Reuters Web of Knowledge Science Citation Index (SCI) and the h-index. By any of these measures, the contributions of Joseph F. Fraumeni, Jr., M.D., are remarkable. December 2012 Linkage Newsletter.
-
Joseph Fraumeni: A 50-Year Legacy of Cancer Research
In July 2012, Joseph F. Fraumeni, Jr., M.D., reached a career milestone of 50 years at NCI. He marked this anniversary by stepping down as Director of DCEG, while continuing to serve as a senior investigator and advisor at NCI and NIH. December 2012 issue of Linkage newsletter.
-
DCEG News Article: The DES Follow-Up Study
Newsletter description of the follow-up study on diethylstilbestrol (DES), with history of events and timeline.
-
Unraveling Genetic Susceptibility to Melanoma
Kevin Brown and colleagues used whole-genome sequencing to identify a novel, recurrent mutation in MITF, a familial and sporadic melanoma predisposition gene.
-
Cancer Risk Among Immunosuppressed Populations
Cancer Risk Among Immunosuppressed Populations discusses studies of organ transplant recipients and HIV-infected individuals and persons with AIDS. Linkage newsletter, 2012.
-
Diesel Exhaust Exposure in Miners Linked to Lung Cancer
Summary of findings from the 20-year Diesel Exhaust in Miners Study
-
U.S. population data show no increase in brain cancer rates during period of expanding cell phone use
In an examination of US cancer incidence data, investigators at the NCI reported incidence trends have remained roughly constant for glioma, the main type of brain cancer hypothesized to be related to cell phone use.
-
Women with BRCA1 and BRCA2 mutations survive ovarian cancer at higher rates than those without mutations
Results from an multi-center study provides strong evidence that women with ovarian cancer who had variants in BRCA1 and BRCA2 were more likely to survive in the five years following diagnosis.
-
Women exposed to DES in the womb face increased cancer risk
Daughters of women who had been given DES, the first synthetic form of estrogen, during pregnancy found exposure to the drug in utero was associated with many reproductive problems and increased risk of certain cancers and pre-cancerous conditions.
-
NIH study finds two doses of HPV vaccine may be as protective as full course
Two doses of the human papillomavirus (HPV) vaccine Cervarix were as effective as the current standard three-dose regimen after four years of follow-up.